BioMarin Pharmaceutical Careers | Glassdoor

Find your next job here

BioMarin Pharmaceutical Overview

San Rafael, CA
1001 to 5000 employees
Company - Public (BMRN)
Biotech & Pharmaceuticals
$500 million to $1 billion (USD) per year
BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We remain steadfast to our original mission—to ... Read more

Company Updates


    BioMarin to Present at 35th Annual J.P. Morgan Healthcare Conference in San Francisco

    Jan. 3, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:30 am PT, or 11:30 am ET, in San Francisco, California .


    How Focusing On Obscure Diseases Made BioMarin A $15 Billion Company

    BioMarin became one of the world's most valuable biotechs by jettisoning costly distractions and focusing on one thing: treating some of the rarest diseases on the planet.

See AllSee All

BioMarin Pharmaceutical – Why Work For Us?

Rare Opportunities, Personal Impact

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes

At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options, and are usually ignored.

Time is critical to patients with rare diseases, and we strive to quickly develop important therapies for them. The efficiency and speed of our research, development, manufacturing, and commercial efforts is at the heart of our ability to urgently deliver therapies. Our track record of developing and commercializing new treatments has been significantly faster than the industry average and is ingrained in our culture. CenterWatch, a leading source for global clinical trial information, has named it one of the fastest drug developers in the industry. BioMarin was also ranked tenth on Forbes list of innovative companies in 2015.

As a biopharmaceutical company, our success stems from our focus on science and the hope our therapies can bring to patients. We are world leaders in metabolic disease innovation with multiple products commercialized and a growing pipeline of product candidates to address unmet medical needs. We continue to fuel our R&D engine by looking for opportunities that align with our strengths and competencies. And we relentlessly pursue exciting, early-stage science that has the potential to change the course of disease.

A constant in BioMarin’s culture is how patients continue to drive us. The passion and dedication that our employees bring to work each day is a testament to the inspiration our patients provide, and the knowledge of the impact we can make in their lives.


What makes working here unique? At BioMarin, we feel the intense tie between the work we do and the life-changing results it delivers. Our focus on rare disease gives us the rare opportunity to truly impact lives.

As employees, we’re here because we want to be here. We enjoy our work — and each other. Our people are smart. Unassuming. Collaborative. Curious. Interesting. We share a passion for shared accomplishment — across teams and across borders — and are committed to our people, our purpose, and most of all, our patients. This common ground elevates the impact each of us is able to make every single day.

Our appetite for science drives us. Our team members motivate us. And our patients inspire us. Together we’re growing a company unlike any other, because our motivation is unlike any other.


At BioMarin, we’re inspired, driven, and empowered by the patients who benefit from our therapies. Continually fueling our R&D engine, we look for opportunities to develop first-in-class and best-in-class therapeutics to make a meaningful impact on the lives of those with rare genetic diseases.

Careers at BioMarin include:


From research and discovery to post-market clinical development, our R&D engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with rare diseases.


Our manufacturing and process development teams manage the production of our therapies for clinical trials and commercial markets. These engineers, technicians, scientists, and support professionals continually provide quality assurance and ensure we meet all regulatory standards. We have manufacturing facilities in Northern California and in Cork, Ireland. Additionally, our supply chain teams procure the goods and services needed to support manufacturing and worldwide distribution.


Be part of the worldwide infrastructure that gets our drugs to underserved patients around the world. Our global sales force solidifies BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as South America, EuMEA, and Asia-Pacific.


It takes a village, and at BioMarin, our general and admin teams are the village behind our success. From the IT experts who manage our technology to the human resources professionals who hire the people who make it all possible, these teams support our organization and span all areas of operations.

Meet Megan French, a Senior Process Validation Engineer and BioMarin employee since 2015

What do you enjoy most about working at BioMarin? The scientific approach. At BioMarin, we look at the science behind things and justify what we do from there. It’s unique, and it’s exciting. Our orphan drug status means that our timelines are very short comparatively. It’s also very patient-focused. Management makes a big effort to make sure we, as employees, are aware of our patients’ stories — that we know who we are working for, which is really motivating. There is also a high caliber of people here. We need people with diverse backgrounds — in education and beyond — to address the need for different product aspects.      

Do you see BioMarin as a leader? How so? I would say BioMarin is a leader in innovation. We operate under a different model — we’re not trying to replicate big pharma. We deliver orphan drugs, which means our timeline to market is much faster than at many biopharm companies. This is also a place where, if you have an idea about how something might be done better — there is a forum for your ideas to be heard. We all work together with one goal in mind, and it makes us all really feel like true contributors. We’re working on a lot of new, pioneering technology — things that have never been done before. Gene therapy is exciting and potentially groundbreaking. It takes a lot of courage to be a leader in new technologies, and I think we do it successfully at BioMarin.     

What should candidates know about BioMarin?  BioMarin is at a really great, fantastic stage. It’s big enough that we’re not a startup, but not so big that there isn’t room to have a strong and important impact on our future. The company has more than doubled in the past year, and with tremendous growth comes opportunity.   Beyond that, BioMarin is just a great company to work for, and the work you do is both challenging and fulfilling. I feel that I have a lot of impact on the products I work on, testing, information in submissions, the manufacturing processes themselves. I do not feel that this level of personal influence would be the same at a larger company. It’s very rewarding.  

BioMarin Pharmaceutical Reviews

Rating TrendsRating Trends
Recommend to a friend
Approve of CEO
BioMarin Pharmaceutical Chief Executive Officer Jean-Jacques Bienaimé
Jean-Jacques Bienaimé
102 Ratings
  • Featured Review

    "Great place to work if you are willing to work hard"

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Clinical Operations Manager in San Rafael, CA
    Current Employee - Clinical Operations Manager in San Rafael, CA
    Positive Outlook
    Approves of CEO

    I have been working at BioMarin Pharmaceutical full-time (Less than a year)


    Great learning environment, lots of extremely smart people, room for advancement, study teams are great, flexible hours


    Resourcing issues can come up frequently especially with the location of the office . Commutes can be long for a lot of employees.

    Advice to Management

    While planning out the clinical development plans, evaluate resourcing needs earlier on. Also, management should consult with the study teams on realistic timelines.

See All 220 Reviews

BioMarin Pharmaceutical Photos

BioMarin Pharmaceutical photo of: San Rafael Corporate Campus
BioMarin Pharmaceutical photo of: Where great minds gather
BioMarin Pharmaceutical photo of: Stairs to the cure
BioMarin Pharmaceutical photo of: A nice place for a break
BioMarin Pharmaceutical photo of: The key is in the design
BioMarin Pharmaceutical photo of: Lab Coats
See All PhotosSee All

BioMarin Pharmaceutical Interviews



Getting an Interview

Getting an Interview





    Director of Process Interview

    Anonymous Interview Candidate in Novato, CA
    No Offer
    Neutral Experience
    Average Interview


    I applied online. The process took 2+ months. I interviewed at BioMarin Pharmaceutical (Novato, CA) in February 2018.


    Interviews were pleasant held in Novato and with 7 all male executives. who were professional. The reason of decline from them was another candidate ranked higher but the candidate had not accepted the position yet & could have multiple offers or their background could not have cleared plus the Job is still open on site. Interview could have been to fulfill quota of interviewing a diverse candidate.
    Agree with the prior feedback seems odd that there wasn't one female or diverse exec. on panel.
     Seems decline could have been salary reasons but just seemed unusual.
     I came that far into the process. Process took over 2 months & they had no candidates and probably still don't.

    Interview Questions

See All 94 Interviews

BioMarin Pharmaceutical Awards & Accolades

  • The World's Top 10 Most Innovative Companies, Forbes Magazine, 2016
  • The World's Top 10 Most Innovative Companies(10), Forbes, 2015
  • Top 25 Biotech Companies, Genetic Engineering & Biotechnology News (GEN), 2015
  • Most Admired Company, QB3, 2015
  • The World's Most Innovative Companies, Forbes, 2014
See More

Work at BioMarin Pharmaceutical? Share Your Experiences

BioMarin Pharmaceutical
  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate